🇺🇸 FDA
Pipeline program

CFT8634

CFT8634-1101

Phase 1 small_molecule terminated

Quick answer

CFT8634 for Synovial Sarcoma is a Phase 1 program (small_molecule) at C4 Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
C4 Therapeutics
Indication
Synovial Sarcoma
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials